At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
TCBP TC BioPharm
Post-Market Trading 05-02 16:12:04 EDT
1.45
-0.04
-2.68%
盘后1.45
+0.000.00%
16:03 EDT
High1.49Low1.43Vol44.35K
Open1.47D1 Closing1.49Amplitude4.03%
Mkt Cap4.63MTradable Cap4.62MTotal Shares3.20M
T/O64.68KT/O Rate1.39%Tradable Shares3.19M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
BSGM, WAVE and TCBP among pre-market losers
seekingalpha  ·  04-10
BSGM, WAVE and TCBP among pre-market losers
Altice USA, Genfit, Brooge Energy among premarket losers' pack
seekingalpha  ·  04-05
Altice USA, Genfit, Brooge Energy among premarket losers' pack
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
Benzinga  ·  04-05
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
TC BioPharm Shares Rise 63% After Letter Intent to Buy Cancer Therapy Assets
Dow Jones  ·  04-05
TC BioPharm Shares Rise 63% After Letter Intent to Buy Cancer Therapy Assets
BRNS, UPC and KWE among mid-day movers
seekingalpha  ·  04-05
BRNS, UPC and KWE among mid-day movers
ARCA biopharma, Achilles Therapeutics, MSP Recovery among healthcare movers
seekingalpha  ·  04-04
ARCA biopharma, Achilles Therapeutics, MSP Recovery among healthcare movers
EIGR, ADXN and BROG are among premarket gainers
seekingalpha  ·  04-04
EIGR, ADXN and BROG are among premarket gainers
TC Biopharm shares jump on signing non-binding LOI for two allogeneic CAR-NK therapeutics
seekingalpha  ·  04-04
TC Biopharm shares jump on signing non-binding LOI for two allogeneic CAR-NK therapeutics
TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies
StreetInsider  ·  04-04
TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies
BRIEF-TCBP Increasing Treatment Capacity With Expanded Manufacturing Process
Reuters  ·  04-03
BRIEF-TCBP Increasing Treatment Capacity With Expanded Manufacturing Process
TCBP to raise treatment capacity with expanded manufacturing process
seekingalpha  ·  04-02
TCBP to raise treatment capacity with expanded manufacturing process
TCBP Increasing Treatment Capacity with Expanded Manufacturing Process
PR Newswire  ·  04-02
TCBP Increasing Treatment Capacity with Expanded Manufacturing Process
CGC, ATOS and MODG are among pre market gainers
seekingalpha  ·  03-20
CGC, ATOS and MODG are among pre market gainers
Canopy Growth, Outlook Therapeutics, Immuneering among healthcare movers
seekingalpha  ·  03-18
Canopy Growth, Outlook Therapeutics, Immuneering among healthcare movers
TCBP Announces Exercise of Series D Warrants For Cash
PR Newswire  ·  03-18
TCBP Announces Exercise of Series D Warrants For Cash
FGEN, LEXX and SGLY among mid-day movers
seekingalpha  ·  03-13
FGEN, LEXX and SGLY among mid-day movers
Lexicon Pharmaceuticals, Mesoblast, Ventyx Biosciences among healthcare movers
seekingalpha  ·  03-11
Lexicon Pharmaceuticals, Mesoblast, Ventyx Biosciences among healthcare movers
US Stocks Down; Dow Falls 100 Points
Benzinga  ·  03-11
US Stocks Down; Dow Falls 100 Points
ETRN, CRDF and KC are among pre market gainers
seekingalpha  ·  03-11
ETRN, CRDF and KC are among pre market gainers

Introduction

Company Name.
TC BioPharm
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Issue price:
--